Tracking the Recruitment of Diabetogenic CD8+ T-Cells to the Pancreas in Real Time

Author:

Moore Anna1,Grimm Jan2,Han Bingye3,Santamaria Pere3

Affiliation:

1. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts

2. Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

3. Julia McFarlane Diabetes Research Center and Department of Microbiology and Infectious Diseases, University of Calgary, Alberta, Canada

Abstract

Development of autoimmune diabetes in both humans and mice is preceded by a prolonged period of inflammation of pancreatic islets by autoreactive T-cells. Noninvasive imaging techniques, including positron-emission tomography and optical or magnetic resonance imaging, have been used to track the recruitment of lymphocytes to sites of inflammation. These techniques, however, rely on labeling strategies that are non–antigen specific and do not allow specific tracking of the recruitment of autoreactive lymphocytes. Here we describe an antigen-specific magnetic label to selectively target a prevalent population of diabetogenic CD8+ T-cells that contribute to the progression of insulitis to overt diabetes in NOD mice. Superparamagnetic nanoparticles coated with multiple copies of a high-avidity peptide/major histocompatibility complex ligand of these T-cells (NRP-V7/Kd) are endocytosed by CD8+ T-cells in an antigen-specific manner. Using these T-cells as probes, we show that inflammation of pancreatic islets by autoreactive T-cells can be detected in real time by magnetic resonance imaging. This study demonstrates the feasibility of visualizing the presence of ongoing autoimmune responses noninvasively.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference37 articles.

1. Liblau R, Wong S, Mars L, Santamaria P: Autoreactive CD8+ T-cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17:1–6,2002

2. Weissleder R: Molecular imaging: exploring the next frontier. Radiology 212:609–614,1999

3. Oku N, Koike C, Sugawara M, Tsukada H, Irimura T, Okada S: Positron emission tomography analysis of metastatic tumor cell trafficking. Cancer Res 54:2573–2576,1994

4. Koike C, Watanabe M, Oku N, Tsukada H, Irimura T, Okada S: Tumor cells with organ-specific metastatic ability show distinctive trafficking in vivo: analyses by positron emission tomography and bioimaging. Cancer Res 57:3612–3619,1997

5. Kikkawa H, Tsukada H, Oku N: Usefulness of positron emission tomographic visualization for examination of in vivo susceptibility to metastasis. Cancer 89:1626–1633,2000

Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Noninvasive strategies of cell-tracking in vivo;TrAC Trends in Analytical Chemistry;2024-03

2. Particle-Based therapies for antigen specific treatment of type 1 diabetes;International Journal of Pharmaceutics;2023-01

3. Nano-biomaterials for therapeutic and diagnostic applications;Applications of Multifunctional Nanomaterials;2023

4. Molecular Imaging and Theranostics;Advances in Imaging;2022

5. Immunomodulatory and immunoregulatory nanomedicines for autoimmunity;Seminars in Immunology;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3